Advanced Biomed Inc. (ADVB)
NASDAQ: ADVB · Real-Time Price · USD
5.30
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Advanced Biomed Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Market Capitalization | 7 | 15 | - | - | - | - |
| Enterprise Value | 5 | 12 | - | - | - | - |
| Last Close Price | 5.30 | 14.00 | - | - | - | - |
| PB Ratio | 0.60 | 4.36 | - | - | - | - |
| P/TBV Ratio | 0.76 | 4.36 | - | - | - | - |
| Debt / Equity Ratio | 0.08 | 0.36 | 0.55 | 0.18 | 0.13 | 0.01 |
| Net Debt / Equity Ratio | -0.20 | -0.47 | -1.02 | -1.83 | -1.24 | -0.06 |
| Net Debt / EBITDA Ratio | 0.64 | 0.61 | 0.79 | 0.84 | 1.91 | 0.03 |
| Net Debt / FCF Ratio | 0.31 | 0.28 | 0.77 | 0.75 | 2.65 | 0.12 |
| Quick Ratio | 2.15 | 1.09 | 1.03 | 0.85 | 1.65 | 2.34 |
| Current Ratio | 8.56 | 2.09 | 1.12 | 0.85 | 1.67 | 32.22 |
| Return on Equity (ROE) | 80.18% | -126.79% | -187.43% | -155.62% | -180.30% | - |
| Return on Assets (ROA) | -26.90% | -34.42% | -35.07% | -33.93% | -38.45% | - |
| Return on Capital Employed (ROCE) | -34.40% | -83.40% | -147.10% | -231.90% | -63.80% | -187.80% |
| Earnings Yield | 60.64% | -21.51% | - | - | - | - |
| FCF Yield | -84.55% | -38.66% | - | - | - | - |
| Buyback Yield / Dilution | -6.73% | -2.63% | -0.32% | -40.55% | -23.74% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.